Creative Biolabs-Immuno-oncology

Anti-FOLH1 (clone 2EA1G0Z) SynExpress T7-Cy2-GR-E Modified CD8+ T cells (CAT#: ITS-1224-CR408)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target FOLH1 (clone 2EA1G0Z). We employs the Adenovirus (T7-Cy2-GR-EcoRI) vector components and the SynExpress system of the Single base pair Prime Editing/Positive feedback for a robust and sustained response against cancers.
Host
human
Target
FOLH1
Clone
2EA1G0Z
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy2
Promoter
T7
Effector Gene
GR
Insertion Sites
EcoRI
Gene Modification
Prime Editing
Modification Domain
Single base pair
Carrier Type
Adenovirus
Transformation Accuracy
0.88
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving